TrialSignal transduction and targeted therapy2026

Targeting an IL-17/IL-36 pathogenic hub in hidradenitis suppurativa with a bispecific antibody.

Yonghu Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.